BiotechTubeBiotechTube
Home/H.U. Group Holdings/Hironobu Nakamura
HN

Hironobu Nakamura

Managing Executive Officer, President of Fujirebio Inc.

H.U. Group Holdings

Therapeutic Areas

OncologyNeurologyInfectious DiseaseGeneral Healthcare

H.U. Group Holdings Pipeline

DrugIndicationPhase
Lumipulse G β-Amyloid Ratio (1-42/1-40)Alzheimer's Disease DiagnosisApproved
Lumipulse G pTau181Alzheimer's Disease DiagnosisLaunched
HISCL™ Assay PortfolioVarious (Infectious Disease, Tumor Markers)Commercial
Tumor Marker Portfolio (PSA, CA125, etc.)Various CancersCommercial
Companion Diagnostics (CDx) PartnershipsOncology (Various Targets)Development & Commercial

Leadership Team at H.U. Group Holdings

SM
Shuji Morita
President and Representative Director, Group CEO
TM
Tatsuya Maruyama
Senior Managing Executive Officer, Group CFO
HO
Hiroshi Oshima
Senior Managing Executive Officer, President of SRL, Inc.
YW
Yoko Wake
Independent Outside Director (Attorney-at-law)
TI
Tetsuya Iizuka
Independent Outside Director (Professor)
MG
Masahiko Gemma
Independent Outside Director (Corporate Auditor)
View full H.U. Group Holdings profile